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Introduction
That chemical exposures can produce inflammation and that sensory nerves are involved in this process have been recognized since the early 1900s. In 1910 Bruce demonstrated that the inflammatory response to chemical irritants can be abolished by ablation of sensory nerves (1) . This response is widely known. The red eyes, nasal congestion, and sinus headaches that arise from being stuck in the fumes of rush-hour traffic, sitting in a smoky bar, or painting with organic solvent-based paints are examples of inflammation from exposures to chemical irritants. This reactivity to chemicals can be altered in some people, and it is recognized that some people have a heightened inflammatory response to chemical irritants. A role for neurogenic inflammation in chemical sensitivity has been reviewed (2) . This altered reactivity to chemicals is best known in rhinitis and asthma, with asymptomatic when patients were fasted on spring water with control of both inhalants and ingestants in an environmental control unit (7) . In addition, mental symptoms such as hallucinations, depression, and mania were described as improving when these patients were removed from the chemical environment. Elimination routines included both inhalants and ingestants. Symptoms were provoked by reexposure to foods and chemicals.
It is natural to consider neurogenic inflammation as a possible mechanism of chemical sensitivity. For many decades it has been known that sensory neurons are involved in an inflammatory process, and that this neurogenic inflammation is triggered by chemicals that stimulate these sensory neurons. For most people, these reactions are mild and fleeting and are resolved with the individual's removal to fresh air. For some people, exposures such as these can trigger debilitating illness with reactions lasting several days.
The work of Bascom and her collaborators is significant. A physiological response to inhalant chemicals was demonstrated in challenge studies with environmental tobacco smoke (ETS). As Bascom pointed out, this response is consistent with neurogenic inflammation (8) .
My research in this area began when patients with chemical sensitivity were referred to an allergy clinic. These patients complained of an intolerance to chemicals associated with exposures to solvents or pesticides. Physical examination, particularly when supplemented with fiberoptic rhinolaryngoscopy, revealed severe inflammation of the upper airway in these patients. Findings included edema, abnormal mucus, cobblestoning (lymphoid hyperplasia), and friability of the mucosa. One puzzling finding that we consistently saw was focal areas of white mucosa with prominent blood vessels (4). Initially we thought this might represent atrophy of the mucosa, but biopsies performed for clinical diagnosis in selected patients revealed no atrophy, and no difference between the white and red areas of the mucosa. To our surprise, there was chronic inflammation of the mucosa with lymphocytic infiltrates in the biopsy specimens. A preliminary research study with controls was undertaken. The picture that is emerging is depicted schematically in Figure 1 . Figure 1A is a schematic of the anatomy of normal respiratory epithelium.
Abnormalities of the nasal mucosa suggested by this study were lymphocytic infiltrates, glandular hyperplasia, proliferation of peripheral nerve fibers, gaps in the tight junctions between epithelial cells, and focal areas of desquamation of the epithelium (9) . These abnormalities are depicted schematically in Figure 1B . An example of an electron micrograph of a patient is shown in Figure 2 , with defects in tight junctions between respiratory epithelial cells and desquamation of epithelial cells visible. Attempts to study the distribution of substance P and vasoactive intestinal polypeptide (VIP) in these specimens with immunoperoxidase stains specific for these substances were unsuccessful because currently available reagents stain multiple sites in tissue specimens in a nonspecific pattern.
In the study by Meggs et al. (9), the presence of inflammation in patients relative to controls was statistically significant (p<O.05). This study did not have the power to verify statistically the nerve fiber proliferation that was seen in chemically sensitive subjects relative to that in controls.
The switching (17) . The pathways involved as well as the relationship between neurogenic inflammation and allergic inflammation are depicted in Figure 3 . Table 2 characterizes allergic rhinitis, arising from mast cell degranulation in the upper airway as seen at Site B in Figure 3 , and chemical irritant rhinitis, arising from substance P release from the sensory nerves, as shown at Site A in Figure 3 . Figure 4 . Another factor that may come into play is that lymphocytes may have specific antigen receptors for chemicals; this occurs in contact dermatitis. The details of the proposed mechanism are depicted schematically in Figure 5 . Dotted lines indicate relationships that are at this time suggested by data but not rigorously established.
Mechanism of Acquired
The proliferation of peripheral nerve fibers described here has been seen in other instances of inflammatory response and is termed remodeling (20) . This remodeling effect may be produced by nerve growth factor activity, and it is known that lymphocytes have this activity (21) .
Relationships between RADS, RUDS, and MCS
Three of the possible scenarios for the relationships between RADS, RUDS, and MCS are shown in Figure 6 . If these disorders are separate, i.e., no relationships, one might see some incidental overlaps due to unfortunate individuals who may have two or all three of these disorders ( Figure 6A ).
Another scenario is depicted in Figure 6B , which suggests that RADS and RUDS are subsets of MCS. These patients would have MCS but have airway inflammation as a very prominent component of their disease. RADS is depicted as a subset of RUDS because patients with lower airway inflammation generally have some degree of upper airway inflammation. Figure 6C depicts the possibility that RUDS and MCS are the same disorder, with the primary lesion being upper airway inflammation and symptoms in other organ systems arising from neurogenic switching. Figure 6C is such as chemicals in the airway, infections, allergies, and emotional stress could result in excitation of these pathways.
Research Needs
Much work is still to be done on this model, as summarized in Table 3 . Basic science needs include the elucidation of the chemoreceptors on the sensory nerves. These receptors are thought to be proteins on the sensory nerve membranes and need to be isolated so they can be sequenced and have their structures studied. Clinically, there is a specificity to the response to chemicals. Some patients with severe chemical sensitivities have been known to tolerate substances that are devastating to others. For example, not all patients with asthma are aversely affected by exposure to 
